|
RBL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.904100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.682100E-02 |
| Normal-vs-Stage2 |
2.211200E-01 |
| Normal-vs-Stage3 |
3.887400E-01 |
| Normal-vs-Stage4 |
1.750390E-01 |
| Stage1-vs-Stage2 |
8.870000E-01 |
| Stage1-vs-Stage3 |
3.489200E-01 |
| Stage1-vs-Stage4 |
8.615200E-01 |
| Stage2-vs-Stage3 |
6.305000E-01 |
| Stage2-vs-Stage4 |
8.117400E-01 |
| Stage3-vs-Stage4 |
4.752000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.726200E-02 |
| Normal-vs-AfricanAmerican |
5.537700E-02 |
| Normal-vs-Asian |
1.422030E-01 |
| Caucasian-vs-AfricanAmerican |
3.94310000000342E-05 |
| Caucasian-vs-Asian |
1.561390E-01 |
| AfricanAmerican-vs-Asian |
6.054300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.412100E-02 |
| Normal-vs-Female |
1.665440E-01 |
| Male-vs-Female |
8.322600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.463000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.558100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.526800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.612600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.204800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.170000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.715800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.063200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.440500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.667580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.447700E-02 |
| Normal-vs-Grade 2 |
4.772000E-02 |
| Normal-vs-Grade 3 |
3.098800E-01 |
| Normal-vs-Grade 4 |
3.279800E-01 |
| Grade 1-vs-Grade 2 |
5.865400E-01 |
| Grade 1-vs-Grade 3 |
2.873200E-01 |
| Grade 1-vs-Grade 4 |
3.942800E-01 |
| Grade 2-vs-Grade 3 |
1.678420E-01 |
| Grade 2-vs-Grade 4 |
7.234600E-01 |
| Grade 3-vs-Grade 4 |
7.267200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.818000E-03 |
| Normal-vs-ccB subtype |
2.833400E-01 |
| ccA subtype-vs-ccB subtype |
3.098400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.853700E-02 |
| Normal-vs-N1 |
1.890150E-01 |
| N0-vs-N1 |
4.186800E-01 |
|
|
